In 2018, estimated U.S. revenue from the legal cannabis business was $11 billion. Some estimate this will rise to $19–23 billion by 2022, on par with beer and wine. How can your company take part in this growing industry while minimizing risk? Our panelists will address the potential future regulatory hurdles of bringing cannabis-related products to market. In this presentation, you will learn:
- Takeaways from the May 31, 2019 Part 15 public hearing and the outlook for the FDA’s regulatory landscape as companies bring CBD products to market
- Examples of CBD products that have successfully navigated hurdles to manufacture, distribution, marketing, and sales
- Guardrails for downstream risk, including transportation and waste disposal, including DEA Disposal Act compliance
Questions? Please contact Abby Forness at firstname.lastname@example.org or 404.881.7824.